Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
13.91
+0.22 (1.61%)
At close: Oct 5, 2026, 4:00 PM EDT
13.94
+0.03 (0.20%)
After-hours: Oct 5, 2026, 7:49 PM EDT
Generate Biomedicines Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $30 | Buy | Reiterates | $30 | +115.67% | Oct 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $26 | Buy | Reiterates | $26 | +86.92% | Oct 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $22 | Buy | Reiterates | $22 | +58.16% | Aug 17, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $30 | Buy | Reiterates | $30 | +115.67% | Jun 25, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $26 | Buy | Maintains | $26 | +86.92% | Apr 10, 2026 |